HCA Healthcare, Inc. earnings per share and revenue
On 24 de out. de 2025, HCA reported earnings of 6.96 USD per share (EPS) for Q3 25, beating the estimate of 5.77 USD, resulting in a 20.55% surprise. Revenue reached 19.16 bilhão, compared to an expected 18.75 bilhão, with a 2.21% difference. The market reacted with a +1.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 23 analistas forecast an EPS of 7.50 USD, with revenue projected to reach 19.86 bilhão USD, implying an aumentar of 7.76% EPS, and aumentar of 3.66% in Revenue from the last quarter.
FAQ
What were HCA Healthcare, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, HCA Healthcare, Inc. reported EPS of $6.96, beating estimates by 20.55%, and revenue of $19.16B, 2.21% above expectations.
How did the market react to HCA Healthcare, Inc.'s Q3 2025 earnings?
The stock price moved up 1.56%, changed from $440.16 before the earnings release to $447.04 the day after.
When is HCA Healthcare, Inc. expected to report next?
The next earning report is scheduled for 22 de jan. de 2026.
What are the forecasts for HCA Healthcare, Inc.'s next earnings report?
Based on 23
analistas, HCA Healthcare, Inc. is expected to report EPS of $7.50 and revenue of $19.86B for Q4 2025.